Alfonso Gonzalez-Rodriguez
Internal Medicine · Orlando, FLNPI 1629091384
Payments from drug & device makers
What this record shows
18 manufacturers reported payments, led by CSL Behring at 33.0% of the total. Reporting peaked in 2024 at $3,432 and has fallen 68.3% since, to $1,088 in 2025. Among internal medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 92 payments — averaging $62.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$2K
- Merck$1K
- Novartis$978
- Johnson & Johnson$577
- Sunovion Pharmaceuticals Inc.$161
- Abbott$146
- plus $888 from 12 others
Across 546 payments — averaging $8675.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Astrazeneca UK Limited$2.1M
- Modernatx, Inc.$714K
- Boehringer Ingelheim International GmbH$472K
- Eli Lilly$360K
- Pfizer$329K
- AstraZeneca$175K
- plus $584K from 9 others
What the payments were for
- Travel & lodging$3,29657%
- Food & beverage$2,45243%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 9 | $1,897 |
| Merck | 8 | $1,101 |
| Novartis | 6 | $978 |
| Johnson & Johnson | 25 | $577 |
| Sunovion Pharmaceuticals Inc. | 10 | $161 |
| Abbott | 1 | $146 |
| Avanir Pharmaceuticals, Inc. | 3 | $141 |
| Lilly USA, LLC | 6 | $137 |
| Viiv Healthcare Company | 10 | $136 |
| Amgen | 1 | $99 |
| Otsuka America Pharmaceutical, Inc. | 1 | $87 |
| Mylan Specialty L.p. | 3 | $75 |
| AstraZeneca | 1 | $50 |
| Exact Sciences | 1 | $46 |
| Sun Pharmaceutical Industries Inc. | 3 | $43 |
| Regeneron | 2 | $43 |
| Acadia Pharmaceuticals Inc | 1 | $16 |
| Scilex Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CARDIOMEMS$146
- XARELTO$124
How this compares
$5,748 in reported general payments places this provider in the 90th percentile of 8,530 internal medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 20 | $8,590 |
| XareltoRivaroxaban | 30 | $8,358 |
| EntrestoSacubitril/Valsartan | 24 | $4,050 |
| Gabapentin | 56 | $1,247 |
| Levetiracetam | 26 | $1,198 |
| Atorvastatin Calcium | 50 | $1,151 |
| Montelukast Sodium | 46 | $1,037 |
| Donepezil Hcl | 28 | $844 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $786 |
| Tamsulosin Hcl | 35 | $714 |
| Humalog Kwikpen U-100Insulin Lispro | 14 | $655 |
| Amlodipine Besylate | 52 | $619 |
| Metoprolol Tartrate | 44 | $576 |
| Hydralazine Hcl | 29 | $524 |
| Metformin Hcl | 40 | $481 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $577 | $8,35830 claims |
| NovartisEntresto | $978 | $4,05024 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,530 internal medicine providers in Florida.
Other internal medicine in Orlando
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Quang NguyenOcala$434K
- Luis Correa LunaSanford$412K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
- Howard FederoffCoconut Grove$302K
- Bianka EperjesiovaGainesville$260K
- Julio ConradoFort Myers$247K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.